Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|32|5036-5044

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.32, 2012-11, pp. : 5036-5044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabis Use and Psychosis: Theme Introduction

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4991-4998

Bentham Science Publishers

Access to resources Recommend Favorite

Stress and the Prodromal Phase of Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 527-533

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabis use and cognitive functions in at-risk mental state and first episode psychosis

By Bugra H.   Studerus E.   Rapp C.   Tamagni C.   Aston J.   Borgwardt S.   Riecher-Rössler A.  

Psychopharmacology, Vol. 230, Iss. 2, 2013-11 ,pp. : 299-308

Springer Publishing Company

Access to resources Recommend Favorite

Anandamide Dysfunction in Prodromal and Established Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5188-5193

Bentham Science Publishers

Access to resources Recommend Favorite

Philosophical Issues in the Prodromal Phase of Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 596-605

Bentham Science Publishers

Access to resources Recommend Favorite